Pharmaceutical

Report Name Published
Global Preimplantation Genetic Diagnosis Market Size, Status and Forecast 2025

This report studies the global Preimplantation Genetic Diagnosis market, analyzes and researches the Preimplantation Genetic Diagnosis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Genesis Genetics - Genea Limited - Illumina, Inc. - Laboratory Corporation of America Holdings - Natera, Inc. - PerkinElmer, Inc - Quest Diagnostics Incorporated - Reprogenetics - Reproductive Genetics Innovations LLC Market segment by Regions/Countries, this report covers - United States - EU - Japan - China - India - Southeast Asia Market segment by Type, the product can be split into - PGD for Aneuploidy Screening - PGD for Chromosomal Aberrations - PGD for Gender Selection - PGD for HLA Typing - PGD for Single Gene Disorder - PGD for X-linked diseases Market segment by Application, Preimplantation Genetic Diagnosis can be split into - Fertility Clinics - Health Care Facilities (including hospitals, diagnostic centers, and health care facilities) - Academic Institutes and Research Centers If you have any special requirements, please let us know and we will offer you the report as you want.

2018
Global Food Allergy Market Size, Status and Forecast 2025

This report studies the global Food Allergy market, analyzes and researches the Food Allergy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Alletess Medical Laboratory - ALS Limited - Asurequality Ltd - Charm Sciences - Crystal Chem, Inc - Danaher Corporation - Intertek Group - Merieux Nutrisciences Corporation - Microbac Laboratories - Neogen Corporation - Omega Diagnostics Group - Perkin Elmer Market segment by Regions/Countries, this report covers - United States - EU - Japan - China - India - Southeast Asia Market segment by Type, the product can be split into - Blood Test - Skin Test Market segment by Application, Food Allergy can be split into - For Baby Food - For Bakery & Confectionary Products - For Dairy Products - For Fish and Sea Food - Other If you have any special requirements, please let us know and we will offer you the report as you want.

2018
Global Contract Pharmaceutical Manufacturing Market Research Report 2018

In this report, the global Contract Pharmaceutical Manufacturing market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Contract Pharmaceutical Manufacturing in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - India Global Contract Pharmaceutical Manufacturing market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including - Catalent - DPx - Lonza - Piramal Healthcare - Aenova - Jubilant - Famar - Boehringer Ingelheim - Fareva Holding - AbbVie - Nipro Corp - Vetter - Sopharma - DPT Laboratories - Recipharm - NextPharma - Dishman - Aesica On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into - Active Pharmaceutical Ingredients (API) - Finished Dosage Formulations (FDF) On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including - Big Pharma - Specialty/Midsize - Generics - Other If you have any special requirements, please let us know and we will offer you the report as you want.

2018
Global Zika Virus Vaccines Market Research Report 2017

In this report, the global Zika Virus Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Zika Virus Vaccines in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Global Zika Virus Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including NHI Sanofi GSK Bharat. Takeda Inovio Pharmaceuticals GeneOne Life Science Inc PaxVax Gilead Sciences Inc. Intrexon Corp. NewLink Genetics Corp On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into DNA Vaccine Inactivated Vaccine Purified Inactivated Vaccine

2018
Patient Derived Xenograft/PDX Models Market 2017-2022

PDX models market is projected to grow at a CAGR of 16.7%” The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period. The various players in the PDX models market include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International, Inc. (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd. (China), Xentech (France), Horizon Discovery Group PLC (UK), Urolead (France), and Explora BioLabs (US). Research Coverage: The report analyzes the PDX models market and aims at estimating the market size and the future growth potential of this market based on various segments such as type, tumor type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies. This report provides insights on the following pointers: Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global PDX models market Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global PDX models market Market Development: Comprehensive information about the lucrative emerging markets by type, tumor type, application, end user, and region Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global PDX models market Competitive Assessment: In-depth assessment of growth strategies, products, and services of leading players in the market

2018
Pharma Extractables and Leachables Testing Market 2018 - 2023

This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2017 while forecasts have been provided from 2018 to 2023. The pharma E&L testing market is expected to expand at a compound annual growth rate of 15.3% from 2017 to 2023, driven by the increasing adoption of single use technologies, increased demand due to stringent regulatory scrutiny, CROs evolving as development partners and increasing prominence of biologics leading to need for comprehensive E&L testing programs. With the increasing prominence of single use systems (SUS), the global E&L testing market is expected to experience a robust growth. Emerging markets such as India and China are becoming hubs for contract manufacturing for such services, as these countries are building strong local expertise in analytical laboratory testing. The pharma industry is becoming more aware of the impact of E&L for protection of patients, leading to increased and stringent scrutiny by regulatory agencies. Bio/Pharma companies are increasingly outsourcing these services to reduce the burden on internal staff and also expedite the time to market for drugs.

2018
Portugal Nuclear Imaging Equipment Market Outlook to 2022

Summary GlobalData's new report, "Portugal Nuclear Imaging Equipment Market Outlook to 2022", provides key market data on the Portugal Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems. *Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends) The report also provides company shares and distribution shares data for the market segment, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to market size, company share, pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Nuclear Imaging Equipment market segments Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market segments. Data is provided from 2008 to 2015 and forecast to 2022. - 2015 company shares and distribution shares data for Nuclear Imaging Equipment market. - Global corporate-level profiles of key companies operating within the Portugal Nuclear Imaging Equipment market. - Key players covered include Siemens Limited, GE Healthcare Limited, Philips Healthcare and Others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

2018
Global Nuclear Medicine/Radiopharmaceutic Market Research Report 2018

In this report, the global Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceutic in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - India Global Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including - Company - Bracco Imaging - Bayer - Mallinckrodt - Nordion - Triad Isotopes - Lantheus - IBA Group - GE Healthcare - China Isotope & Radiation - Jubilant Pharma - Eli Lilly - Advanced Accelerator Applications - SIEMENS - Dongcheng - Navidea On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into - Diagnostic Radioisotopes - Therapeutic Radioisotopes On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including - Oncology - Cardiology - Others If you have any special requirements, please let us know and we will offer you the report as you want.

2018
Global Pharmacy Automation Systems Market Research Report 2018

In this report, the global Pharmacy Automation Systems market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pharmacy Automation Systems in these regions, from 2013 to 2025 (forecast), covering - - North America - - Europe - - China - - Japan - - Southeast Asia - - India Global Pharmacy Automation Systems market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including - - Capsa Healthcare - - Cerner Corporation - - Baxter International - - ScriptPro - - ARxIUM Inc. - - Parata Systems - - Talyst Systems - - KUKA - - TCGRx Pharmacy Workflow Solutions - - RxSafe - - Becton Dickinson and Company On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into - - Automated Medication Dispensing Systems - - Automated Packaging And Labelling Systems - - Automated Table Top Counters - - Automated Medication Compounding Systems - - Automated Storage And Retrieval Systems On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including - - Inpatient Pharmacies - - Outpatient Pharmacies - - Pharmacy Benefit Management Organization And Mail Order Pharmacies - - Retail Pharmacies If you have any special requirements, please let us know and we will offer you the report as you want.

2018
Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size, Status and Forecast 2025

This report studies the global Biopharmaceutical Contract Manufacturing(BCMO) market, analyzes and researches the Biopharmaceutical Contract Manufacturing(BCMO) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Lonza Group Ltd Boehringher Ingelheim Sandoz Fujifilm Diosynth Biotechnology Rentschler Biotechnologie Celonic GmbH BIOMEVA GmbH ProBioGen AG Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, the product can be split into Mammalian Based Manufacturing Microbial Based Manufacturing Other Market segment by Application, Biopharmaceutical Contract Manufacturing(BCMO) can be split into Bio-Pharmaceutical Companies Pharmaceutical Companies Drug Discovery Companies Other If you have any special requirements, please let us know and we will offer you the report as you want.

2018
Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market 2018

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2018-2025 The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2018-2025 report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies. The report provides a detailed understanding and analysis of how and why companies enter business, royalty financing agreements. The focus of the report is on partnerships for royalty assets where partners have entered an agreement to dispose of or acquire said assets. The report provides access to royalty financing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Royalty assets - where a specialist investment company acquires the rights to future royalty payments in return for payment of a lump sum payment to the licensor for the product Revenue assets – also known as ‘synthetic royalties’, where a specialist investment company acquires the rights to a proportion of future revenue streams in return for a lump sum payment to the company Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not. This report provides comprehensive access to royalty and revenue financing deals as announced in the life sciences industry since 2010. This report contains links to online copies of actual royalty financing contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of royalty financing dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in royalty financing dealmaking as well as a discussion on the merits and attributes of royalty financing dealmaking. Chapter 3 provides an overview of the structure of royalty financing deal contracts. The chapter includes numerous case studies to enable understanding of royalty financing deals for royalty assets. Chapter 4 provides a review of the leading royalty financing deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 5 provides a comprehensive listing of royalty financing contract documents since 2010, including deal value, press release and contract document. The chapter is organized by company A-Z. Chapter 6 provides a comprehensive listing of all royalty financing deal announcements and agreement contracts since 2010 available in the public domain. The chapter is organized by company A-Z and therapeutic area. Each deal title links via Weblink to an online version of the deal record and, where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in royalty financing dealmaking. In conclusion, this report provides everything a prospective dealmaker needs to know about royalty financing, enabling thorough learning, education and due diligence prior and during the royalty financing dealmaking process. Key benefits Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2018-2025 provides the reader with the following key benefits: In-depth understanding of royalty financing partnering deal trends since 2010 Analysis of the structure of royalty financing partnering agreements with numerous real life case studies Comprehensive listing of all royalty financing deals since 2010, together with deal terms, value and press release Comprehensive access to actual royalty financing partnering contracts entered into by the world’s biopharma companies Insight into the terms included in a royalty financing partnering agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies Report scope Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2018-2025 is intended to provide the reader with an in-depth understanding of the royalty financing trends and structure of deals entered into by leading biopharma companies worldwide. Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2018-2025 includes: Trends in royalty financing dealmaking in the biopharma industry since 2010 Analysis of royalty financing deal structure Case studies of real-life royalty financing deals Comprehensive listing of royalty financing deals since 2010 Access to royalty financing contract documents The leading royalty financing deals by value since 2010 Most active royalty financing dealmakers since 2010 The leading royalty financing partnering resources

2018
Smart Pills - Global Market Outlook 2017-2026

The Global Smart Pills Market is accounted for $0.55 billion in 2017 and is expected to reach $3.72 billion by 2026 growing at a CAGR of 23.7% during the forecast period. Increasing occurrence of Gastro-intestinal diseases, favorable reimbursement in region and rising cancer screening awareness programs are some of the key factors propelling the market growth. However, technological ineffectiveness of capsule endoscopes and high price of smart pills are hindering the growth of the market. Need for rapid drug development process provides ample of opportunities for the market growth. Smart pills are the medical devices which are utilized in invasive surgeries and have efficiently decreased the gap between healthcare and technology. It contains drug and ingestible sensor which make contact with stomach fluid identifies the type of pill taken by body. It consists of elements such as sensors, cameras and trackers that assist in better diagnostics and supervising. These devices can be easily consumed and offer a non-invasive detailed examination of the gastrointestinal (GI) tract. It is used for screening and treatment of diseases such as gastric ulcers, colorectal cancer and gastroesophageal disorders. Customers of smart pills mainly include aged population, immobile patients, and paralysis patients. By Application, Capsule endoscopy is the part of endoscopy in which a small capsule and pill shaped wireless camera used to examine the digestive system. Factors such as increase in cancer screening awareness programs and raise in prevalence of Crohn’s disease and bowel cancer are fueling the capsule endoscopy market growth. It is intended to provide whole examination of GIT including images of esophagus, stomach, small intestine and large intestine. It causes minimum discomfort and also non-invasive. It is used for identifying colonic disorders, small bowel diseases and esophageal disorder. By Geography, North America is anticipated to dominate the market due to the technological improvement in healthcare sector, raise in prevalence of colorectal cancer, and regulatory approval of new products. Asia Pacific is the fastest growing market owing to disposable income, compulsory healthcare insurance, and increase in healthcare expenses are expected to drive the market. Some of the key players in Smart Pills Market include Cerner Corporation, GE Healthcare, Olympus Corporation, Bio –Images Research Ltd., Acamp, Boston Scientific Corporation, Medimetrics, Fujifilm Holdings Corporation, Capsovision, Inc., Pentax Medical Company, Proteus Digital Health, Inc., Karl Storz Gmbh & Co. KG, Given Imaging, Inc, Medisafe and Medtronic. Target Areas Covered: - Stomach - Large Intestine - Esophagus - Small Intestine Applications Covered: - Drug Delivery - Patient Monitoring - Capsule Endoscopy - Tools Regions Covered: North America Europe Asia Pacific South America Middle East & Africa What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements

2018
ePharmacy - Global Market Outlook 2017-2026

Tthe Global ePharmacy Market is accounted for $44.95 billion in 2017 and is expected to reach $211.36 billion by 2026 growing at a CAGR of 18.7% during the forecast period. Stable rise in the number of internet consumers, enhanced access to web-based & online services and growing implementation of e-prescriptions in hospitals and other healthcare services are some of the key factors fueling the market growth. However, expansion of a large number of unlawful online pharmacies is negatively impacting the growth of the market. E-Pharmacy is a pharmacy that control over the Internet and sends the orders to customers through the mail or shipping companies. With the increasing internet access there has been remarkable change in the online purchasing consumers. It improves customer convenience and access. It will be most advantage for chronic elderly patients and patients who are not in a situation to go out to find a pharmacy. Online and mobile-based consumers are supposed to upload the scanned copy of their prescription and place request. By Geography, North America is anticipated to dominate the largest market share due to rise in online orders and high acceptances of ecommerce are some of the factors fueling in this region. Asia Pacific is the fastest growing market due to the existence of a huge patient pool and increase in target population. Countries such as China and India are expected to growth of the market due to the high growth potential. Some of the key players in ePharmacy market include Wallgreen Pharmacy, DocMorris (Zur Rose Group AG), CVS Health, Walmart Stores, Inc., The Kroger Co., Giant Eagle, Inc., Express Scripts Holding Company, Rowlands Pharmacy, Optum Rx, Inc., Banner Health, PlanetRX.com Inc., Lloyds Pharmacy Ltd, Drugstore.com, Dr. Fox Pharmacy, MediSave, Pharmacy2U, The SANICARE Group, CanadaDrugs.com, CanAmerica Drugs, Inc and The Kroger Company. Regions Covered: North America Europe Asia Pacific South America Middle East & Africa What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements

2018
2018-2025 Artificial Saliva Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

This report studies the Artificial Saliva market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Artificial Saliva market by product type and application/end industries. The global Artificial Saliva market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Artificial Saliva. United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX. Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Artificial Saliva in these regions, from 2013 to 2025 (forecast), covering United States North America Europe Asia-Pacific South America Middle East and Africa The major players in global and United States market, including GlaxoSmithKline plc Cipla Limited Mission Pharmacal Company Fresenius Kabi Parnell Pharmaceuticals, Inc. CCMed Group Entod International Midatech Pharma Plc. Forward Science Valeant Pharmaceuticals International, Inc. Biocosmetics Laboratories Icpa Health Products LTD. Perrigo Laboratorios Kin, S.A. On the basis of product, the market is primarily split into Oral Spray Oral Solution Oral Liquid Gel Powder On the basis on the end users/application, this report covers Adult Paediatric

2018
Global Pharmaceutical Membrane Filtration Market By Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material)and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Pharmaceutical Membrane Filtration Market was valued at USD 3.47 billion in 2016 and is projected to reach USD 9.43 billion by 2025, growing at a CAGR of 11.75% from 2017 to 2025. The Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries. It finds extensive applications in the biopharmaceutical industry as products are susceptible to degradation due to heat and chemical treatment. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Growing Demand od pharmaceutical products 1.2 Advances in filtration and Nano filtration 1.3 Increasing applications in control of air borne diseases 1.4 Rise in drug production 1.5 Strong biologics pipeline 2. Market Restraints 2.1 Stringent Guidelines Governing Pharmaceutical Membrane Filtration 2.2 High cost f technology Market Segmentation: 1. Global Pharmaceutical Membrane FiltrationMarket, by Technique: 1.1 Microfiltration 1.2 Ultrafiltration 1.3 Nanofiltration 1.4 Reverse Osmosis 1.5 Ion Exchange 2. Global Pharmaceutical Membrane FiltrationMarket, by Product: 2.1 Mce Membrane Filters 2.2 Coated Cellulose Acetate 2.3 Nylon 2.4 Ptfe Membrane 2.5 Pvdf Membrane 2.6 Other Membrane Filters 3. Global Pharmaceutical Membrane Filtration Market, by Application: 3.1 Final Product Processing 3.2 Raw Material Filtration 3.3 Air Purification 3.4 Cell Separation 3.5 Water Purification 4. Global Pharmaceutical Membrane Filtration Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Merck KGaA 2. General Electric Company 3. Danaher Corporation (Pall Corporation) 4. Sartorius Stedim Biotech S.A. 5. 3M Company 6. Alfa Laval 7. Graver Technologies, LLC 8. Koch Membrane System 9. GEA Group 10. Novasep These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Pharmaceutical Membrane FiltrationMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2018
Global Downstream Processing Market By Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization)and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Downstream Processing Market was valued at USD 10.21 billion in 2016 and is projected to reach USD 39.80billion by 2025, growing at a CAGR of 16.32% from 2017 to 2025. Downstream processing refers to the recovery and purification of biosynthetic products, particularly pharmaceuticals, from natural sources such as animal or plant tissue or fermentation broth, including the recycling of salvageable components and the proper treatment and disposal of waste. With increasing demand of pharmaceutical services, the market is expected to grow in forecast period. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing R&D Expenditure in Biopharmaceutical Companies 1.2 Growing Demand for Biopharmaceuticals 2. Market Restraints 2.1 High initial cost and implementation expenditure Market Segmentation: 1. Global Downstream Processing Market, by Application: 1.1 Monoclonal Antibody Production 1.2 Vaccines Production 1.3 Insulin Production 1.4 Immunoglobulin Production 1.5 Erythropoietin Production 1.6 Other Applications 2. Global Downstream Processing Market, by End User: 2.1 Biopharmaceutical Manufacturers 2.2 Contract Manufacturing Organizations 3. Global Downstream ProcessingMarket, by Product: 3.1 Chromatography Columns and Resins 3.2 Filters 3.3 Membrane Adsorbers 3.4 Single-Use Products 3.5 Other Products 4. Global Downstream Processing Market, by Technique: 4.1 Clarification/Concentration 4.2 Solid-Liquid Separation 4.2.1 Filtration 4.2.2 Separation 4.3 Purification Techniques 4.3.1 Gel Chromatography 4.3.2 Ion Exchange Chromatography 4.3.3 Affinity Chromatography 4.3.4 Hydrophobic Interaction Chromatography 5. Global Downstream Processing Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Thermo Fisher Scientific Inc. 2. GE Healthcare 3. Sartorius Stedim Biotech S.A. 4. Merck Millipore 5. Danaher Corporation 6. 3M Company 7. BoehringerIngelheim 8. Lonza Group AG 9. Eppendorf AG 10. Finesse Solutions, Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Downstream ProcessingMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2018
Global Pharmaceutical Filtration Market By Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D)and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Pharmaceutical Filtration Market was valued at USD 13.65 billion in 2016 and is projected to reach USD 33.64billion by 2025, growing at a CAGR of 10.45% from 2017 to 2025. Filtration and purification needs in the Pharmaceutical Manufacturing Industry are extensive and significant. The manufacturing of drugs and pharmaceutical products has increased with current healthcare scenario all over the globe. The market is thus expected to grow In coming years. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Technological Advancements in Biologics and Large Molecules 1.2 Increasing Advancements in the Nanofiber Technology 1.3 Growing Generic Drug Production 1.4 Increasing Need for Clean and Safe Research and Manufacturing Environment 2. Market Restraints 2.1 Stringent Government Regulations Market Segmentation: 1. Global Pharmaceutical FiltrationMarket, by Scale of Operation: 1.1 Manufacturing-Scale Operations 1.2 Pilot-Scale Operations 1.3 R&D-Scale Operations 2. Global Pharmaceutical FiltrationMarket, by Application: 2.1 Cell Separation 2.2 Water Purification 2.3 Air Purification 2.4 Raw Material filtration 2.4.1 Media and Buffer Filtration 2.4.2 Prefiltration 2.4.3 Bioburden Testing 2.5 Final product processing 2.5.1 Active Pharmaceutical Ingredient Filtration 2.5.2 Sterile Filtration 2.5.3 Protein Purification 2.5.4 Vaccine and Antibody Processing 2.5.5 Formulation and Filling Solution Filtration 2.5.6 Viral Clearance 3. Global Pharmaceutical FiltrationMarket, by Technique: 3.1 Microfiltration 3.2 Ultrafiltration 3.3 Nanofiltration 3.4 Other Techniques 4. Global Pharmaceutical Filtration Market, by Product: 4.1 Membrane Filters 4.2 Single-Use Systems 4.3 Cartridge & Capsule Filters 4.4 Filter Holders 4.5 Filtration Accessories 4.6 Prefilters& Depth Media Filters 4.7 Other Products 5. Global Pharmaceutical Filtration Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Merck KGaA 2. GE Healthcare 3. Pall Corporation 4. Parker Hannifin Corporation 5. Sartorius Stedim Biotech S.A. 6. 3M Company 7. Eaton Corporation PLC 8. Amazon Filters Ltd. 9. Graver Technologies, LLC 10. Meissner Filtration Products, Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Pharmaceutical FiltrationMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2018
Global Cell Signaling Market By Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology)and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Cell Signaling Market was valued at USD 2.32 billion in 2016 and is projected to reach USD 4.18billion by 2025, growing at a CAGR of 6.75% from 2017 to 2025. With expansion in Genetic make-up based therapeutics and pharmaceuticals, the role of cell signaling pathways and their mechanism have become significant for the R&D purposes. With prevalence of chronic disorders, the market is expected to grow at a high CAGR. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Rising Incidence of Chronic Diseases 1.2 Availability of Funding for Cell-Based Research 1.3 Technological Advancements in Cell-Based Research Instruments 1.4 Growth of End-Use Industries 2. Market Restraints 2.1 High Cost of Cell Signaling Systems 2.2 Ethical Issues Related to Embryonic Stem Cell Signaling Research Market Segmentation: 1. Global Cell SignalingMarket, by Product: 1.1 Consumables 1.1.1 Antibodies 1.1.2 Reagents 1.1.3 Assay Kits 1.1.4 Other Consumables 1.2 Instruments 2. Global Cell SignalingMarket, by Signaling Type: 2.1 Endocrine Signaling 2.2 Paracrine Signaling 2.3 Autocrine Signaling 2.4 Juxtacrine Signaling 2.5 Other Signaling Types 3. Global Cell SignalingMarket, by Pathway: 3.1 AKT Signaling Pathway 3.2 AMPK Signaling Pathway 3.3 ErbB/HER Signaling Pathway 3.4 Hedgehog Signaling Pathway 3.5 JAK/STAT Signaling Pathway 3.6 Notch Signaling Pathway 3.7 NF-KB Signaling Pathway 3.8 Other Signaling Pathways 4. Global Cell Signaling Market, by Technology: 4.1 Microscopy 4.2 Flow Cytometry 4.3 Mass Spectrometry 4.4 Western Blotting 4.5 ELISA 4.6 Immunohistochemistry 4.7 Other Technologies 5. Global Cell Signaling Market, by Application: 5.1 Medical applications 5.2 Research applications 5.2.1 Cancer Research 5.2.2 Immunology Research 5.2.3 Stem Cells Research 5.2.4 Other Research Applications 6. Global Cell Signaling Market, by Region: 6.1 North America (U.S., Canada, Mexico) 6.2 Europe (Germany, UK, France, Rest of Europe) 6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 6.4 Latin America (Brazil, Argentina, Rest of Latin America) 6.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Merck KGaA 2. Thermo Fisher Scientific Inc. 3. Becton, Dickinson and Company 4. Beckman Coulter Inc. (A Subsidiary of Danaher Corporation) 5. Bio-Rad Laboratories, Inc. 6. Perkinelmer, Inc 7. Qiagen N.V. 8. Cell Signaling Technology, Inc. 9. Promega Corporation 10. Bio-Techne Corporation These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Cell SignalingMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2018
Global Depth Filtration Market By Media Type (Diatomaceous Earth, Activated Carbon, Cellulose), Product (Filter Cartridge, Capsule Filter), Application (Final Product Processing (Small Molecules, Biologics), Cell clarification)and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Depth Filtration Market was valued at USD 1.50 billion in 2016 and is projected to reach USD 4.03 billion by 2025, growing at a CAGR of 11.65% from 2017 to 2025. Depth filters are the variety of filters that use a porous filtration medium to retain particles throughout the medium, rather than just on the surface of the medium. Increase in R&D Activities and investments would be the key factors to drive the growth of market in the forecast period. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Growth in the Production of Biologics and Large Molecules 1.2 R&D Expenditure in Pharmaceutical and Biopharmaceutical Companies 1.3 Advantages Such as Low Cost and Ease of Use 2. Market Restraints 2.1 Stringent Government Regulations for the Validation of Filtration Processes Market Segmentation: 1. Global Depth FiltrationMarket, by Application: 1.1 Final product processing 1.1.1 Small Molecule Processing 1.1.2 Biologics Processing 1.2 Cell Clarification 1.3 Raw material Filtration 1.3.1 Media and Buffer Filtration 1.3.2 Bioburden Reduction 1.4 Others 2. Global Depth FiltrationMarket, by Product: 2.1 Cartridge Filters 2.2 Capsule Filters 2.3 Filter Modules 2.4 Filter Sheets 2.5 Other Products 3. Global Depth FiltrationMarket, by Media Type: 3.1 Diatomaceous Earth 3.2 Activated Carbon 3.3 Cellulose 3.4 Perlite 4. Global Depth Filtration Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Merck KGaA 2. Pall Corporation (A Subsidiary of Danaher Corporation) 3. Parker-Hannifin Corporation 4. Sartorius Stedim Biotech S.A. 5. 3M Company 6. Eaton Corporation PLC 7. Amazon Filters Ltd. 8. Ertelalsop 9. Graver Technologies, LLC 10. Meissner Filtration Products, Inc. 11. Filtrox AG 12. Fileder Filter Systems Ltd. 13. Carl Stuart Group (Pure Process) 14. WolftechnikFiltersysteme GmbH & Co. Kg 15. Saint-Gobain Performance Plastics These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Depth FiltrationMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2018
Global Protein Assays Market By Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab)and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Protein Assays Market was valued at USD 1.27 billion in 2016 and is projected to reach USD 3.27billion by 2025, growing at a CAGR of 11.07% from 2017 to 2025. Protein assays are an integral part of biotechnology and pharmaceutical researches. With increasing demand of medicinal treatments and efficient diagnostic services, the market is expected to grow in the forecast period. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Pharmaceutical and Biotech R&D Expenditure 1.2 Favorable Government Funding Scenario for Proteomics Research 2. Market Restraints 2.1 High Cost of Multiplex Assay Equipment 2.2 Sequestration Cuts in the U.S. Market Segmentation: 1. Global Protein AssaysMarket, by End User: 1.1 Pharmaceutical and Biotechnology Companies 1.2 Clinical Laboratories 1.3 Hospitals 1.4 Academic Research Institutes 1.5 Other End Users 2. Global Protein AssaysMarket, by Application: 2.1 Drug Discovery & Development 2.2 Disease Diagnosis 2.3 Other Applications 3. Global Protein AssaysMarket, by Technology: 3.1 Absorbance-Based Protein Assays 3.2 Colorimetric Protein Assays 3.3 Fluorescence-Based Protein Assays 4. Global Protein Assays Market, by Product: 4.1 Reagents 4.2 Kits 4.3 Instruments and Accessories 5. Global Protein Assays Market, by Type: 5.1 Dye-Binding Assays 5.2 Copper-Ion-Based Assays 5.3 Test Strip-Based Assays 5.4 Other Protein Assays 6. Global Protein Assays Market, by Region: 6.1 North America (U.S., Canada, Mexico) 6.2 Europe (Germany, UK, France, Rest of Europe) 6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 6.4 Latin America (Brazil, Argentina, Rest of Latin America) 6.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Bio-Rad Laboratories, Inc. 2. Thermo Fisher Scientific Inc. 3. Merck KGaA 4. Promega Corporation 5. GE Healthcare 6. Perkinelmer, Inc. 7. Geno Technology, Inc. 8. Cell Signaling Technology, Inc. 9. Abcam PLC. 10. Novus Biologicals, LLC 11. Soltec Ventures (Soltec Bio Science) 12. Lonza Group 13. Biovision Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Protein AssaysMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2018